We are live on ! Find out more
IE

Israel Englander Millennium Management

AUM $276B
1-Year Est. Return 44.8%
 

Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.

This Fund
S&P 500
This Quarter Est. Return
+6.05%
1 Year Est. Return
+44.8%
3 Year Est. Return
+127.22%
5 Year Est. Return
+155.52%
10 Year Est. Return
+768.06%
AUM
$54.6B
AUM Growth
+$6.83B
Cap. Flow
+$4.44B
Cap. Flow %
8.13%
Top 10 Hldgs %
5.74%
Holding
4,184
New
894
Increased
1,327
Reduced
1,188
Closed
743

Sector Composition

Rank Sector Weight
1 Financials 12.61%
2 Technology 11.6%
3 Healthcare 11.38%
4 Energy 10.68%
5 Industrials 10.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
YUME
3376
DELISTED
YuMe, Inc.
YUME
$53K ﹤0.01%
+13,071
New +$47.5K
INNL
3377
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$53K ﹤0.01%
+47,606
New +$38.1K
CTLP
3378
DELISTED
Cantaloupe
CTLP
$52K ﹤0.01%
+12,235
New +$51.8K
NUWE icon
3379
Nuwellis
NUWE
$3.33M
0
SNGX icon
3380
Soligenix
SNGX
$8.81M
$52K ﹤0.01%
+81
New +$47.2K
PIM
3381
Franklin Master Intermediate Income Trust
PIM
$152M
$51K ﹤0.01%
+10,974
New +$51.3K
PLG
3382
Platinum Group Metals
PLG
$207M
$51K ﹤0.01%
3,105
-3,917
-56% -$68.1K
ONVI
3383
DELISTED
Onvia, Inc.
ONVI
$51K ﹤0.01%
11,657
-343
-3% -$1.52K
DHY
3384
Credit Suisse High Yield Credit Fund
DHY
$236M
$50K ﹤0.01%
+18,841
New +$51K
MRKR icon
3385
Marker Therapeutics
MRKR
$25M
$50K ﹤0.01%
1,103
-1,358
-55% -$60.4K
PULM icon
3386
Pulmatrix
PULM
$5.66M
$50K ﹤0.01%
+71
New +$42.3K
NVIV
3387
DELISTED
InVivo Therapeutics Holdings Corp
NVIV
$48K ﹤0.01%
1
-7
-88% -$566K
REXX
3388
DELISTED
Rex Energy Corporation
REXX
$48K ﹤0.01%
+10,162
New +$61.1K
MBVX
3389
DELISTED
MABVAX THERAPEUTICS HLDGS INC
MBVX
$46K ﹤0.01%
6,791
-3,438
-34% -$29.8K
MACK
3390
PUT
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$46K ﹤0.01%
+1,881
New +$47.1K
KNDI
3391
Kandi Technologies Group
KNDI
$65.1M
$44K ﹤0.01%
+11,604
New +$49.7K
ZDGE icon
3392
Zedge
ZDGE
$37.8M
$44K ﹤0.01%
14,433
-7,452
-34% -$24.7K
ARQL
3393
DELISTED
Arqule Inc
ARQL
$44K ﹤0.01%
+41,569
New +$55.5K
HBIO icon
3394
Harvard Bioscience
HBIO
$34.4M
$43K ﹤0.01%
1,644
-1,253
-43% -$36.1K
ANTH
3395
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$43K ﹤0.01%
12,582
-34,949
-74% -$165K
CDMO
3396
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$42K ﹤0.01%
+9,199
New +$30.8K
CXRX
3397
DELISTED
Concordia International Corp. Common Stock
CXRX
$42K ﹤0.01%
25,966
-206,059
-89% -$444K
AFMD
3398
DELISTED
Affimed
AFMD
$41K ﹤0.01%
1,766
-4,406
-71% -$96.9K
YDKG
3399
Yueda Digital Holding
YDKG
$5.64M
$40K ﹤0.01%
7
-7
-50% -$34.7K
BTG icon
3400
B2Gold
BTG
$7.56B
$40K ﹤0.01%
14,200
-1,747,879
-99% -$5.26M

Similar funds

Israel Englander's Q1 2017 Portfolio in Review

As of Q1 2017, Israel Englander held 4,184 positions worth $54.6B, up 14% from $47.8B the previous quarter. Its ten largest holdings account for 5.7% of the portfolio.

Israel Englander deployed $4.44B of net new capital in Q1 2017, opening 894 new positions and adding to 1,327 existing holdings. Its largest new stake was Mondelez International: 3,261,215 shares worth $140M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Bank of New York Mellon, an estimated $251M trimmed.

  • Israel Englander's largest Q1 2017 buy was Mondelez International: 3,261,215 shares worth $140M.
  • Israel Englander added most to Comerica in Q1 2017, an estimated $221M increase.
  • Israel Englander's biggest Q1 2017 reduction was Bank of New York Mellon, cutting an estimated $251M.
  • Israel Englander fully exited Occidental Petroleum in Q1 2017, selling an estimated $171M.
  • Israel Englander's ten largest holdings make up 5.7% of its $54.6B portfolio in Q1 2017.
  • Israel Englander opened 894 new positions and closed 743 in Q1 2017.
  • Israel Englander's portfolio value rose 14% quarter-over-quarter to $54.6B.

Based on Millennium Management's 13F filing for Q1 2017, filed 15 May 2017.